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Abstract
Excess iron accumulation in the brain has been shown to be related to a variety of neurodegenerative
diseases. However, identiﬁcation and characterization of iron compounds in human tissue is diﬃcult
because concentrations are very low. For the ﬁrst time, a combination of low temperature magnetic
methods was used to characterize iron compounds in tumour tissue from patients with mesial temporal lobe
epilepsy (MTLE). Induced magnetization as a function of temperature was measured between 2 and 140 K
after cooling in zero-ﬁeld and after cooling in a 50 mT ﬁeld. These curves reveal an average blocking
temperature for ferritin of 10 K and an anomaly due to magnetite at 48 K. Hysteresis measurements at 5 K
show a high coercivity phase that is unsaturated at 7 T, which is typical for ferritin. Magnetite concen-
tration was determined from the saturation remanent magnetization at 77 K. Hysteresis measurements at
various temperatures were used to examine the magnetic blocking of magnetite and ferritin. Our results
demonstrate that low temperature magnetic measurements provide a useful and sensitive tool for the
characterisation of magnetic iron compounds in human tissue.
Introduction
In the brain, iron plays an important role in normal
neurological functions such as neurotransmitter
synthesis and myelination. It is an essential compo-
nent of physiological processes, such as oxygen and
electron transport, but can also be toxic, acting as a
catalyst for the production of free radicals. Many
neurodegenerative diseases, such as Alzheimer’s and
Parkinson’s disease, are associated with a disruption
of iron metabolism (Beard et al. 1993). Iron-induced
epilepsy and electrophysiological responses are de-
scribed in several studies (Ueda et al. 1998; Ueda &
Willmore 2000) and iron overloadmay even lead to a
predisposition to epilepsy (Ikeda 2001).
The primary iron storage system in most living
organisms is in the form of nanoparticles of fer-
rihydrite (5Fe2O3 · 9H2O) encapsulated by a
spherical protein shell. This iron storage protein,
ferritin, maintains iron in an available soluble,
non-toxic form. Each protein shell of ferritin
consists of 24 polypeptide subunits forming an
approximately spherical cage of 12 nm in diame-
ter. Potentially toxic ferrous iron is sequestered by
the shell and oxidized in the core. The internal
cavity has a diameter of approximately 8 nm and
is occupied by the ferrihydrite core which under-
goes antiferromagnetic ordering at low tempera-
ture and has a net magnetic moment arising from
frustrated surface spins due to its small size
(Massover 1993; Harrison & Arosio 1996;
BioMetals (2005) 18:191–197  Springer 2005
DOI 10.1007/s10534-004-6253-y
Chasteen & Harrison 1999; Seehra et al. 2000).
Many low temperature magnetometry studies have
been performed on horse spleen ferritin (Mohie-
Eldin et al. 1994; Makhlouf et al. 1997; Luis et al.
1999; Gilles et al. 2002) and Dubiel et al. (1999)
identiﬁed ferritin in globus pallidus tissue from the
human brain. These authors found that ferritin in
the brain had a smaller average core diameter and
blocking temperature than ferritin in horse spleen.
Biogenic magnetite is another iron compound
that has been identiﬁed in human brain tissue
(Kirschvink et al. 1992; Dobson & Grassi 1996;
Schultheiss-Grassi & Dobson 1999; Hautot et al.
2003) and in tumour tissue (Kobayashi 1997).
Magnetite (Fe3O4) is a ferrimagnetic iron oxide
with an inverse spinel structure. It contains alter-
nating sublattices of Fe2+ and Fe3+ ions, which
are antiferromagnetically coupled. The alternation
of the two sublattices with unequal numbers of
unpaired electron spins leads to magnetite’s strong
ferrimagnetic magnetization. There is preliminary
evidence that biogenic magnetite is associated with
Alzheimer’s disease and some studies have sug-
gested that it may be responsible for the triggering
of epileptiform activity (Fuller et al. 1995) and the
production of free radicals (Schafer et al. 2000).
Though the source of biogenic magnetite is still
unknown, it has been suggested that ferritin may
be a precursor for magnetite. If the ferritin protein
becomes overloaded or if there is a malfunction in
the iron transport channels, a mechanism for Fe2+
oxidation is lost (Quintana et al. 2000; Dobson
2001; Zhao et al. 2003).
Magnetometry methods, which were devel-
oped for investigations of magnetic materials,
including sediments and rocks, are eﬀective at
detecting small concentrations of magnetic iron
compounds within diamagnetic and paramagnetic
matrices (Maher 1999; Evans 2003). These
methods can provide proxy information on the
iron compounds that are present in addition to
their concentration, and in the case of magnetite,
its particle size. Few studies have detected ferritin
in the human brain with magnetic methods. The
aim of this study is to identify ferritin and bio-
genic magnetite in brain tumour tissue from
mesial temporal lobe epilepsy (MTLE) patients
and to determine which magnetic methods are
most suitable for the characterisation of these
iron oxides in brain tissue.
Material and methods
Two brain tissue samples, GH (gemistocytic
astrocytoma, WHO grading II) and NU (gan-
glioglioma, WHO grading I), were resected from
patients with MTLE and immediately frozen at
)80 C. Four types of magnetic measurements
were made: (1) acquisition of isothermal remanent
magnetization (IRM); (2) thermal demagnetiza-
tion of low temperature IRM; (3) measurement of
induced magnetization (DC susceptibility) as a
function of temperature; (4) induced magnetiza-
tion as a function of ﬁeld (hysteresis curves). All
sample holders, vials, glass ware and surgical
instruments used for the sample preparation were
soaked in HCl for at least 24 h and rinsed with
distilled water to prevent contamination. Precau-
tions were taken to avoid contaminations, as de-
scribed in earlier studies (Dobson & Grassi 1996),
and all samples were weighed prior to measuring.
Acquisition of IRM is useful in identifying
ordered, blocked magnetic phases in a material
because the measured remanent magnetization is
not aﬀected by diamagnetic or paramagnetic
materials in the sample, such as tissue and heme
iron. For IRM experiments frozen tissue samples
were placed in a pre-cooled teﬂon holder and put
into liquid nitrogen. The IRM measurements were
done on a 3-axis 2G Enterprises Superconducting
Quantum Interference Device (SQUID) with a
sensitivity level of 10 · 10)12 Am2. First, the
empty teﬂon holder was measured at 77 K and
then the tissue was placed in the holder and mea-
sured in the same manner. The IRM was acquired
in an ASC Scientiﬁc Pulse Magnetizer Model IM-
10–30, where the sample was exposed to a pulsed
DC ﬁeld. First, a pulse of 1 Tesla was applied to
the sample and the magnetization was measured.
Then, the sample was turned 180 and ﬁelds from
10 mT to 1 T were given in the opposite direction.
After each pulse, the remanent magnetization in
the tissue was measured after 120 s. Afterwards,
the tissue was removed and the sample holder was
demagnetized in a 150 mT AC ﬁeld, to remove the
acquired IRM. The procedure was repeated for the
empty teﬂon sample holder so that the signal of
the holder could then be subtracted from the total
IRM signal of the holder and sample.
Thermal demagnetization of low temperature
IRM was made on tissue samples that were
freeze-dried to remove water. The freeze-dried
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tissue was pressed into a cylindrical pellet within
a diamagnetic straw using teﬂon pistons made for
this purpose. Thermal demagnetization of low
temperature IRM was measured with a Quantum
Design Magnetic Property Measurement System
(MPMS) SQUID Magnetometer at the University
of Bremen. The samples were initially cooled
down to 2 K either in the absence of a magnetic
ﬁeld (zero-ﬁeld cooled, ZFC) or in the presence of
a strong 5 T ﬁeld (ﬁeld cooled, FC). At 2 K a
ﬁeld of 5 T was applied and then turned oﬀ to
give an isothermal remanent magnetization. The
samples were then heated to 300 K while mea-
suring the magnetic moment in intervals of 2 K.
The MPMS is equipped with an internal ﬁeld
compensation coil and has a residual ﬁeld of less
than 100 lT.
Measurements of induced magnetization as a
function of temperature or ﬁeld were also made on
a MPMS SQUID magnetometer at the University
of Bremen. In the thermal experiments samples
were initially cooled to 2 K, either in the absence
of a magnetic ﬁeld (ZFC) or in the presence of a
weak 50 mT ﬁeld (FC). At 2 K a magnetic ﬁeld of
50 mT was applied and the sample was then
heated to 100 K with the magnetic moment mea-
sured at intervals of approximately 2 K. Sample
magnetization was also measured as a function of
ﬁeld (hysteresis loop) at 5, 25, 77 and 300 K, in
ﬁelds from )7 to 7 T after cooling the samples in
zero ﬁeld.
Results
Isothermal remanent magnetization (IRM)
All IRM acquisition curves show a rapid increase
in magnetization in low ﬁelds and saturation is
reached by 200 mT (Figure 1). The shape of the
curve is suggestive of the ferrimagnetic minerals
magnetite and/or maghemite (c-Fe2O3 – an oxi-
dation product of magnetite with slightly smaller
saturation magnetization). By giving the samples a
saturation magnetization in one direction and then
acquiring the IRM in the antipodal direction, it is
possible to obtain the coercivity of remanence
(Hcr). The values are 35 and 25 mT for GH and
NU, respectively, and are approximately the same
at 77 K and room temperature. A diﬀerence in
saturation remanence of 7.1 · 10)7 and 3.7 · 10)7
Am2/kg between the IRM at 300 K and the IRM
at 77 K can be seen for GH and NU, respectively,
and is due to ultraﬁne particles in the sample that
are superparamagnetic at RT but ferrimagnetic at
77 K.
Thermal demagnetization of low temperature
isothermal remanent magnetization
The initial IRM intensities of GH and NU at 2 K
are 4.5 · 10)4 and 3.3 · 10)4 Am2/kg, respec-
tively, when cooled in zero ﬁeld. On heating, there
is a sharp decrease in intensity of magnetization
between 2 K and 20 K. The ﬁeld-cooled samples
show a higher initial IRM intensity at 2 K of
6.4 · 10)4 for GH and 4.6 · 10)4 Am2/kg for NU.
Again, there is a sharp decrease of magnetization
on heating between 2 and 30 K. A slight change in
slope is seen in the ZFC curve between 10 and
12 K (Figure 2). For both samples the FC and
ZFC curves superimpose indistinguishably at a
temperature between 55 and 60 K.
Induced magnetization: DC susceptibility
The measurement of the induced magnetic mo-
ment as a function of temperature in a constant
ﬁeld after ZFC or FC is a useful method in the
characterization of horse spleen ferritin (Mohie-
Eldin et al. 1994; Makhlouf et al. 1997; Friedman
et al. 1997; Gilles et al. 2000). Figure 3 shows the
DC susceptibility as a function of temperature for
ZFC and FC. Both curves superimpose above the
bifurcation point at approximately 60 K. This
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Figure 1. Acquisition of Isothermal Remanent Magnetization
(IRM) at 77 and 300 K for sample GH, showing a low coer-
civity phase and saturation between 200 and 300 mT.
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point indicates the maximum blocking tempera-
ture of the particles in the sample. The FC curve
increases rapidly below this temperature, but does
not follow the Curie–Weiss law for paramagnetic
behaviour. The ZFC curve exhibits two local
maxima at 10 and 48 K. The local maximum
around 10 K is typical for the magnetic ordering
of ferritin in both horse spleen (Makhlouf et al.
1997) and the human brain (Dubiel et al. 1999).
The second local maximum at 48 K is typical for
pure magnetite (Walz & Kronmuller 1991; Walz &
Kronmuller 1994; Moskowitz et al. 1998;
Muxworthy 1999). There is a very strong increase
in the ZFC curve below 6 K, which suggests fur-
ther blocking of a magnetic phase; this will be
discussed below.
Induced magnetization: hysteresis
The magnetic hysteresis curves are dominated by a
strong diamagnetic signal from the tissue also re-
ported by Hautot et al. (2003). The diamagnetic
signal can be removed from the total signal by
subtracting the ﬁt to the curve at 300 K, which is
linearly dependent on temperature. Removal of
the linear component will also remove any con-
tribution to the magnetization from paramagnetic
materials as they also have a linear, albeit positive
response. After the removal of the linear compo-
nents at 300 K, a weak, closed hysteresis loop re-
mains (Figure 4a). The magnetization is saturated
by approximately 200 mT, which is typical for
magnetite and/or maghemite. The hysteresis at
77 K is similar to the loop at 300 K, but the
intensity of the saturation magnetization increases
from 7.7 · 10)5 to 7.8 · 10)4 Am2/kg (Figure 4b).
This indicates the further ordering in the low
coercivity phase. At 25 K, the hysteresis loop has a
contribution from a phase with higher coercivity,
which can be attributed to the ordering of ferritin
(Figure 4c). The loop is nearly closed, since the
average blocking temperature of the ferritin was
determined to be 10 K. Therefore, most of the
particles in the sample are already in the super-
paramagnetic state. The lower coercivity phase is
still present. The intensity of the magnetization at
7 T is 13 · 10)3 Am2/kg. At 5 K, the hysteresis
loop after ZFC is open and dominated by the
ferritin (Figure 5). The magnetization at 7 T is
26 · 10)3 Am2/kg and the ordered phase has a
coercivity of about 50 mT.
Discussion
Both brain samples reveal clearly the presence of
two magnetic compounds. Room temperature
measurements and the measurements at 77 K are
dominated by a low coercivity phase, while at
low temperature a high coercivity phase is
predominant.
The low coercivity phase at room temperature
and 77 K is evident in the results of the IRM
measurements and the hysteresis curves and is
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Figure 2. Field cooled (FC) and zero-ﬁeld cooled (ZFC) ther-
mal demagnetization curves of sample GH.
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Figure 3. Induced ZFC-magnetization curves as a function of
temperature for sample GH between 2 and 100 K in an applied
ﬁeld of 50 mT. The inset shows the FC- and ZFC curves.
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suggested to be magnetite and/or maghemite. The
shape of the IRM curves (Figure 1), typically
showing saturation between 200 and 250 mT, and
the small remanent coercivity (Hcr) between 20 and
30 mT are consistent for either of these materials.
Induced magnetization measurements (Figure 3)
reveal an anomaly around 50 K that has only been
reported for low temperature behaviour in pure
magnetite (Walz & Kronmuller 1991; Walz &
Kronmuller 1994; Moskowitz et al. 1998;
Muxworthy 1999). Assuming that single-domain
magnetite is responsible for the magnetization, an
estimate of the magnetite concentration of ordered
grains in the tissue can be made from the satura-
tion IRM at 77 K, using a value of 46 Am2/kg for
Js/2 (Moskowitz 1993). This value assumes an
ensemble of randomly oriented, non-interacting
particles. A concentration of 69 and 82 ng/g can
be calculated for samples GH and NU, respec-
tively. These values are comparable to earlier
studies on magnetite concentration in hippocam-
pus tissue from epileptic patients (Schultheiss-
Grassi & Dobson 1999). It should be noted that
the estimated concentration is temperature-
dependent due to the presence of superparamag-
netic grains. Below 77 K, the high coercivity phase
becomes predominant, which can be seen in hys-
teresis measurements at 25 and 5 K (Figures 4c
and 5). The hysteresis remains closed at 25 K, even
though we see a low coercivity phase in the IRM
acquisition curves. This is because the magnetiza-
tion of the ferritin dominates the induced magne-
tization at low temperature. The hysteresis at 5 K
shows an Hcr of 50 mT. There is a strong increase
in the magnetization intensity of the high coer-
civity phase with decreasing temperature. Both
curves show no saturation at a ﬁeld of 7 T. FC and
ZFC curves from the thermal demagnetization
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Figure 4. Hysteresis curves from )7 to 7 T of sample GH after
subtracting the linear components from the curve. (a) Hyster-
esis at 300 K, (b) hysteresis at 77 K, (c) hysteresis at 25 K (Note
the change in scale).
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Figure 5. Hysteresis at 5 K from )7 to 7 T of sample GH. The
inset shows the coercivity ﬁeld of 50 mT.
195
measurements decrease rapidly between 2 and
30 K and join between 55 and 60 K (Figure 2).
For the induced magnetization measurements, the
FC and ZFC curves superimpose also at a tem-
perature of 60 K (Figure 3). The phase shows
ordering between 6 and 12 K that causes the local
maximum around 10 K.
Results from all three magnetic methods sup-
port ferritin as the high coercivity phase. The in-
crease in the contribution to intensity and the
increase in coercivity seen in the hysteresis curves,
the local maxima found in the ZFC curves of the
induced magnetization and thermal demagnetiza-
tion and the superposition of the ZFC and FC
curves are characteristic for ferritin. Hysteresis
measurements are very similar to measurements
done for horse spleen ferritin. Perfect antiferro-
magnets (AFM) do not show hysteresis, therefore
the open loops are probably due to the switching
of frustrated surface spins at the ferritin core or to
a defect moment (Ne´el 1962). The ordering tem-
perature between 6 and 12 K is also typical for
ferritin; horse spleen ferritin has an average
blocking temperature from 10 to 20 K (Kilcoyne
& Cywinski 1995; Makhlouf et al. 1997; Friedman
et al. 1997; Gilles et al. 2000). The only magnetic
study on human brain ferritin from globus pallidus
by Dubiel et al. (1999) reports an average blocking
temperature of 8.5 K. The distribution of particle
volume, energy barriers and therefore blocking
temperatures is known from many superpara-
magnetic systems. At the bifurcation point of FC
and ZFC curves, the largest particle in the sample
starts to be unblocked and the whole sample is
superparamagnetic above 60 K. The FC and ZFC
curves of both thermal demagnetization and
induced magnetization superimpose at this tem-
perature. This is in agreement with the results
reported for horse- and human spleen ferritin by
Allen et al. (2000).
The strong increase of magnetic moment below
6 K might be due to a paramagnetic phase in the
tissue, such as heme iron from blood in the tissue.
Blood is reported to show no irregularity in the
ZFC curve; the induced magnetization after FC
and ZFC superimpose and show a paramagnetic-
like decay (Mosiniewicz-Szablewska et al. 2003).
Similar behaviour of induced magnetization as a
function of temperature has been reported for
synthetically formed iron-oxyhydroxide cores
inside the protein shell apoferritin using sol-gels
(Rao et al. 2001). An open question is whether the
behaviour below 6 K can be due to (1) a mutated
ferritin core, which forms a diﬀerent iron phase or
(2) an additional crystalline or non-crystalline
phase within the ferritin core. The inﬂuence of
blood on the magnetic properties at low tempera-
ture will be the focus of a future investigation.
Our measurements show that it is possible to
obtain consistent results from diﬀerent methods
that support two magnetic phases, ferritin and
magnetite, in tumour tissue from human brain
resected from the mesial temporal lobe from
MTLE patients.
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